Al Sandrock On His First Mission At Voyager: Cracking The Tau Alzheimer’s Puzzle
Ex-Biogen Research Head Prioritizes Anti-Tau Antibody
Interview: Twelve months on from exiting Biogen, Al Sandrock is once again leading innovation in neuroscience, and hopes to crack the tau nut in Alzheimer’s and prove that Voyager’s next-generation gene therapy system will be a breakthrough.
